Epcoritamab (Anti-CD20 & CD3)
Product Specifications
CAS Number
2134641-34-0
Synonyms
GEN3013, DuoBody-CD3xCD20
Target
CD markers
Applications
Transmembrane Transporters
Additionnal Information
Epcoritamab is a bispecific IgG1 antibody that targets CD3 and CD20, exhibiting strong T-cell-mediated cytotoxic activity against CD20+ malignant B cells. It is used in the treatment of adults in relapsed or refractory (R/R) large B-cell lymphoma (LBCL), including diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma after ≥2 lines of systemic treatment. MW: 145.26 KD.
Storage Conditions
-80°C (avoid freeze-thaw cycles)
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LC402959 20 µg
GPR86 (P2RY13) (NM_023914) Human Over-expression Lysate
Sign In for Pricing
View Details 
GTR10466825 96 Well
Rat anti-ascaris lumbricoides antibody (IgM) ELISA Kit
Sign In for Pricing
View Details 
GTR15169827 1 Vial
Lentiviral mouse Cyp3a44 shRNA (UAS) - Lentiviral mouse Cyp3a44 shRNA (UAS, iRFP) (100)
Sign In for Pricing
View Details 131843-APC 100 µL
PRMT7 (Protein Arginine N-methyltransferase 7, PRMT-7, KIAA1933, Protein Arginine N-methyltransferase 7, FLJ10640) (APC)
Sign In for Pricing
View Details sc-422562-LAC-2 200 µL
Rab 33B Lentiviral Activation Particles (m2)
Sign In for Pricing
View Details K1610504 1.0 µg DNA
PCGF6 sgRNA CRISPR Lentivector (Human) (Target 3)
Sign In for Pricing
View Details